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Crystalline form of Molnupiravir and process for its preparation thereof
Abstract:

Crystalline

form

of

((2R,3S,4R,5R)-3,4-dihydroxy-5-(4-(hydroxyamino)-2-

oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate of formula (I).

The compound of formula (I) is generally known as “Molnupiravir”. Molnupiravir
(MK-4482/ EIDD-2801) used to mitigate SARS-CoV-2 infection and block transmission in
the ferret model, which resembles the spread in the human young and adult population.
Therapeutic treatment of infected animals with Molnupiravir twice a day significantly
reduced the SARS-CoV-2 load in the upper respiratory tract and completely suppressed
spread to untreated contact animals. This study identified oral Molnupiravir as a promising
antiviral countermeasure to break SARS-CoV-2 community transmission chains.
The present disclosure relates to a crystalline form of Molnupiravir which is
designated as “Form-M”. The Form-M is characterized by powdered X-Ray Diffraction
(PXRD) pattern having characteristic peaks at 3.3, 17.0, 17.2 and 21.03 ± 0.2 degrees 2-theta.
Further, the PXRD pattern of Form-M is illustrated in figure-1.
The process for the preparation of crystalline Form-M of Molnupiravir is described in
the following example.
Example:
Preparation of crystalline Form-M of Molnupiravir
Molnupiravir (350 gm) was added to isopropyl alcohol (3500 ml) at 25-30°C. Raised the
temperature to 65-70°C and stirred for 15 min. at same temperature. Filtered the mixture
through funnel for particle free and washed with isopropyl alcohol. Cooled the mixture to 2530°C and stirred for about 1 hour at same temperature. Further, cooled the reaction mixture to
0-5°C and stirred for 6 hours at same temperature. Filtered the obtained solid, washed with
isopropyl alcohol and then dried to afford the title compound.
Yield: 302 gm, PXRD pattern of obtained compound is illustrated in figure-1.
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Figure-1: PXRD pattern of crystalline Form-M of Molnupiravir is shown below
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